Development and evaluation of a novel series of Nitroxoline-derived BET inhibitors with antitumor activity in renal cell carcinoma.

Name: Development and evaluation of a novel series of Nitroxoline-derived BET inhibitors with antitumor activity in renal cell carcinoma.
Author: Chen, Wei

Development and evaluation of a novel series of Nitroxoline-derived BET inhibitors with antitumor activity in renal cell carcinoma. — المؤلف: Chen, Wei — Oncogenesis Nov 2018

المؤلف: Chen, Wei
النشر: Oncogenesis Nov 2018
الوصف: 83 p.